Skip to the page

Data / Form D filings / NeuroView Technology, Inc.

NeuroView Technology, Inc.: Form D filings

NeuroView Technology, Inc., a company in Englewood, NJ, filed 2 Form D notices with the SEC between 2018 and 2023. The latest, on December 20, 2023, reports $250,002 sold of a $4.8 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
101 HILLSIDE AVENUE, Englewood, NJ, 07631
Phone
(617) 345-3000
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1744796

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 20, 2023New notice$4,820,529$250,002$4,570,5271Dec 13, 2023sec.gov
Jun 29, 2018New notice$5,000,000$304,489$4,695,5116Jun 14, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
James KarwelExecutive Officer, Director
Louis RauchenbergerDirector
Werner Doyle, M.D.Director
Ruben Kuzniecky, M.D.Executive Officer, Director
Steve Pacia, M.D.Director

Other companies in New Jersey that filed recently

Every Form D from the week of Dec 18, 2023 · All recent filings in New Jersey · All recent Other filings

Read from SEC EDGAR. Amount sold is what NeuroView Technology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.